1. Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
   Jung Yoo et al, 2022, Experimental & Molecular Medicine CrossRef
2. Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target
   Yi-Chao Zheng et al, 2019, European Journal of Medicinal Chemistry CrossRef
3. Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
   Anmi Jose et al, 2020, Cancers CrossRef
4. Histone demethylase lysine demethylase 5B in development and cancer
   Mengjiao Han et al, 2017, Oncotarget CrossRef
5. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
   Kuang-Tai Kuo et al, 2018, Clinical Epigenetics CrossRef
6. Targeting JARID1B’s demethylase activity blocks a subset of its functions in oral cancer
   Nicole D. Facompre et al, 2018, Oncotarget CrossRef
7. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
   Dawid Dorna et al, 2022, Cells CrossRef
8. Overcoming radio-resistance in esophageal squamous cell carcinoma via hypermethylation of PIK3C3 promoter region mediated by KDM5B loss
   Xiaobo Wang et al, 2022, Journal of Radiation Research CrossRef
9. Prevention of inorganic arsenic induced squamous cell carcinoma of the skin in Swiss albino mice by black tea through epigenetic modulation
   Archismaan Ghosh et al, 2022, Heliyon CrossRef
10. Targeting histone demethylase KDM5B for cancer treatment
    Yun-Dong Fu et al, 2020, European Journal of Medicinal Chemistry CrossRef
11. KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic
    Shang-Min Zhang et al, 2023, Targeting Lysine Demethylases in Cancer and Other Human Diseases CrossRef